1. Of the judgment of the first instance court, the parts concerning Defendant A, C, D, E, F, Korea Pharmaceutical Export and Import Association, K, and L are as follows.

1. The reasoning for this Court’s explanation concerning this part of the underlying facts is the same as the entry of “1. Basic Facts” in the part of “1. Basic Facts” in the 13th and 20th and lower than the 6th and lower than the 20th and lower than the said 13th judgment of the court of first instance, except in the following cases. As such, this Court’s explanation

▣ 제1심 판결문 16쪽 5째 줄에 있는 “피고 동아제약 주식회사(이하, ‘피고 동아제약’이라고 한다)”를 “피고 동아에스티 주식회사(동아제약 주식회사가 2013. 3. 4. 동아쏘시오홀딩스 주식회사로 상호를 변경하고 전문의약품 등 부분을 인적분할하여 피고 동아에스티 주식회사를 설립하였다. 이하에서는 ‘피고 동아에스티’라 한다)”로 고친다.

▣ 제1심 판결문 19쪽 각주2 의 2째 줄에 있는 “고 한다.”의 다음에 “아래 피고 아이비진은 2009. 5. 21. 대전지방법원 2009하합7 파산결경을 받았으나, 이하에서는 피고 아이비진이라 한다. 아래 한국콜마 주식회사는 2012. 10. 2. 상호를 한국콜마홀딩스 주식회사로 변경하였다가 한국콜마 주식회사를 분할하여 설립하였다. 위 분할설립된 회사를 이하에서는 ‘피고 한국콜마’라 한다.”를 추가한다.

2. Claim against testing bodies and their officers and employees - Defendant A, C, D, E, F, Pharmaceutical Association, K, L

A. As seen earlier, Defendant C, D, E, F, and L, as seen earlier, Defendant C, C, D, E, and F of the Defendant A drafted a false report on the same-sex test in collusion with Defendant B, G, H, I, etc. of the first instance trial in order to manipulate test data. Accordingly, the Food and Drug Administration made a false report on the same-sex test method in collusion with Defendant B, G, H, I, etc. of the first instance trial. Accordingly, the Food and Drug Administration made a false report on the calculation of the same-sex test, the C, C, C, C, and C, C, and C, C, C, and C, and C, E, and C, and C, C, C, and C, E, and C

In addition, the defendant K.K. belonging to the defendant Pharmaceutical Association.